From Name:
From Email:
To Name:
To Email:

Optional Message:


Advisers say FDA's opioid REMS program needs improvement

from ASHP

All 30 voting members of two FDA advisory committees in May urged the agency to change its risk management program for opioid products, with many members backing mandatory training on opioids for prescribers, pharmacists and other members of the healthcare team. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063